References
- Char DH, Miller T. Orbital pseudotumor. Fine needle aspiration biopsy and response to therapy. Ophthalmology. 1993;100:1702–1710
- Henderson JVV. Orbital Tumors. 2nd ed. New York: Brian C. Decker. 1980;512
- Rootman J. Diseases of the Orbit: A Multidisciplinary Approach. Philadelphia: JB Lippincott. 1988; 159–180
- Kennerdell JS, Dresner SC. The nonspecific orbital inflammatory syndromes. Surv Ophthalmol. 1984; 29:93–103
- Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L. What is orbital pseudotumor? Surv Ophthalmol. 1996;41:66–78
- Char DH. Orbital lymphoid lesions and orbital pseudotumors. In Char DH (2nd ed). Clinical Ocular Oncology. Philadelphia: Lippincott-Raven, 1997;398–419
- Jianhua Yan, Zhongyao Wu, Shuqi Huang, Yongping Li. Gene Rearrangement Analysis of Orbital Lymphoid Infiltrating Disorders. Eye Science. 2000;16:15–21
- Cockerham GC, Jackbiec FA. Lymphoproliferative disorders of the ocular adnexa. Int Ophthalmol Clinic. 1997;37:39–59
- Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology. 1996;103:521–528
- Leone CR Jr, Lloyd WC III. Treatment protocol for orbital inflammatory disease. Ophthalmology. 1985;92: 1325–1331
- Glinalp I, Gunduz K, Yazar Z. Idiopathic orbital inflammatory disease. Acta Ophthalmol Scand. 1996;74:191–193
- Weber AL, Romo LV, Sabates NR. Pseudotumor of the orbit: Clinical, pathologic, and radiologic evaluation. Radiologic Clinics of North America. 1999;37: 151–168
- Bertoni F, Bosshard G, Roggero E, Ceresa E, CavaIli F, Zucca E. Clinical relevance of bc1-2(MBR)/Jh rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphoma. British J Cancer. 1997;76:36–39
- Coad JE, Olson DJ, Christensen DR, Lander TA, Chibbar R, McGlennen RC, Brunning RD. Correlation of PCR-detected clonal gene rearrangement with bone marrow morphology in patients with B-lineage lymphomas. Am J Sur PathoL 1997;12: 1047–1056
- Frickhofen N, Muller E, Sandher M, Binder T, Bangerter M, Wiest C, Enz M, Heimpel H. Rearrangement Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia. Blood. 1997; 90:4953–4960
- Hosier GA, Bash RO, Bai X, JaM V, Scheuermann RH. Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma. Am J PathoL 1999;154:1023–1035
- Lopez-Guillermo A, Cabanillas F, McLaughlin P, Smith T, Hagemeister F, Rodriguez MA, Romaguera JE, Younes A, Sarris AH, Alejandro Preti H, Pugh W, Lee MS. The clinical significance of molecular response in indolent follicular lymphomas. Blood. 1998;91: 2955–2960
- McNally L, Jakobiec FA, Knowles DM. Clinical, morphologic, immunophenotypic, and molecular genetic analysis of bilateral ocular adnexal lymphoid neoplasms in 17 patients. Am J Ophthalmol. 1987; 103:555–568
- McNicol AM, Farquarson MA, Lee FD, Foulis AK. Comparison of in situ hybridisation and polymerase chain reaction in the diagnosis of B cell lymphoma. J Clin PathoL 1998; 51:229–233
- Miettinen M, Lasota J. Polymerase chain reaction based gene rearrangement studies in the diagnosis of follicular lymphoma-performance in formaldehyde-fixed tissue and application in clinical problem cases. Pathol Res Pract. 1997;193:9–19
- O'Sullivan MJ, Ritter JH, Humphrey PA, Wick MR. Lymphoid lesions of the gaatrointestinal tract: A histologic, immunophenotypic, and genotypic analysis of 49 cases. Am J Clin PathoL 1998;110:471–477
- Philippe B, Delfau-Larue MH, Epardeau B, Autran B, Clauvel JP, Farcet JP, Couderc U. B-cell pulmonary lymphoma: Gene rearrangement analysis of bronchoalveolar lymphocytes by polymerase chain reaction. Chest. 1999;115:1242–1247
- Sklar J, Longtine J. The clinical significance of antigen receptor gene rearrangements in lymphoid neoplasia. Cancer (supplement). 1992;70: 17 1°–1718
- Stewart CJR, Duncan JA, Farquharson M, Richmond J. Fine needle aspiration cytology diagnosis of malignant lymphoma and reactive lymphoid hyperplasia. J Clin PathoL 1998;51:197–203